CRYAA: Crystallin Alpha A – Key Lens Protein in Cataract and Cancer

Comprehensive genomic, functional, and clinical overview of CRYAA (HGNC:2389) from NCBI, Ensembl, UniProt, OMIM, HGNC, COSMIC, and ClinVar.

Gene Information Card

Symbol CRYAA
Full Name crystallin alpha A
Gene Type protein-coding
Chromosomal Location 21q22.3
NCBI Gene ID 1409 ncbi.nlm.nih.gov/gene/1409
Ensembl ID ENSG00000160211
UniProt ID P02489
OMIM ID 123580
HGNC ID 2389
Aliases CRYA1, HSPB4, CTRCT9

Description

CRYAA encodes alpha-crystallin A, a member of the small heat shock protein family (HSPB4). It functions as a molecular chaperone, preventing protein aggregation in the lens and maintaining transparency. Mutations in CRYAA are associated with autosomal dominant congenital cataract (ADCC) and may contribute to cancer progression via altered chaperone activity.

Disease Associations

Disease category Pathophysiological mechanism Genomic evidence
Autosomal dominant congenital cataract (ADCC) Missense mutations (e.g., R116C, R49C) disrupt chaperone function, leading to protein aggregation and lens opacity. ClinVar, OMIM #123580
Cataract 9 multiple types (CTRCT9) Dominant-negative or loss-of-function mutations cause early-onset cataract. OMIM #604219
Breast cancer CRYAA overexpression correlates with poor prognosis; chaperone activity may protect tumor cells from stress-induced apoptosis. COSMIC, PubMed studies
Lung cancer CRYAA upregulation in non-small cell lung cancer linked to chemoresistance. COSMIC

Expression Profile

Tissue Expression
Tissue nTPM level
Lens — High
Retina — Moderate
Heart — Low
Skeletal muscle — Low
Kidney — Low
Cell Line Expression
Cell Line nTPM Notes
ARPE-19 (retinal pigment epithelium) — Endogenous expression
HLE-B3 (human lens epithelial) — High expression
MCF-7 (breast cancer) — Overexpressed
A549 (lung cancer) — Moderate expression
Data source:Human Protein Atlas(proteinatlas.org)

Mutations & Variants

Hotspot Mutations
Variant Type Frequency Functional Description
R116C Missense Rare Dominant-negative; disrupts chaperone activity; causes congenital cataract
R49C Missense Rare Loss of chaperone function; cataract
W9X Nonsense Rare Truncation; loss of function; cataract
G98R Missense Rare Impaired oligomerization; cataract
D2N Missense Rare Reduced stability; cataract
Mutation functional classification

Loss of Function (LOF)

Nonsense and frameshift mutations (e.g., W9X) produce truncated proteins lacking chaperone activity.

Gain of Function (GOF)

Not well-documented; some missense mutations may cause toxic aggregation.

Dominant Negative (DN)

Missense mutations (e.g., R116C, R49C) interfere with wild-type CRYAA function, leading to cataract.

Pathways

• Unfolded protein response (UPR)
• Small heat shock protein (sHSP) pathway
• Protein processing in endoplasmic reticulum (KEGG: hsa04141)

Protein Summary

Alpha-crystallin A (UniProt P02489) is a 173-amino-acid protein with a conserved alpha-crystallin domain. It forms large oligomeric complexes that bind partially unfolded proteins, preventing aggregation. Post-translational modifications (phosphorylation, deamidation) modulate chaperone activity. In the lens, it is essential for transparency; in other tissues, it protects against stress-induced apoptosis.

Related Products

Product name Cat.No. Species Gene ID
CRYAA Knockout HEK293 Cell Line EDJ-KQ50208 Human 1409 Details Get a Quote
CRYAA Knockout HeLa Cell Line EDJ-KQ52986 Human 1409 Details Get a Quote
CRYAA Knockout A-549 Cell Line EDJ-KQ61453 Human 1409 Details Get a Quote
CRYAA Knockout HCT 116 Cell Line EDJ-KQ69950 Human 1409 Details Get a Quote
Contact Us
*
*
*
How did you hear about us: